text: To compare maintenance epoetin alfa administered once every 3 weeks with continued weekly epoetin alfa for patients with cancer-associated anemia .
entities.text: epoetin alfa
entities.type: intervention
entities.text: epoetin alfa
entities.type: intervention
entities.text: patients with cancer-associated anemia
entities.type: participant